Last reviewed · How we verify
NCT06729788
Resin Infiltrate as Pit and Fissure Sealant in Permanent Molars
Phase 4 trial testing ICON resin infiltration Material group in vivo in Resin Infiltration in 86 participants. Not yet recruiting.
15 November 2025
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Phase | Phase 4 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 86 |
| Start date | 4 January 2025 |
| Primary completion | 15 November 2025 |
| Estimated completion | 24 December 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- ICON resin infiltration Material group in vivo — full drug profile →
- Resin-based fissure sealant group in vivo — full drug profile →
- ICON resin infiltration in vitro — full drug profile →
- Resin-based fissure sealant in vitro — full drug profile →
Conditions studied
- Resin Infiltration — all drugs for Resin Infiltration →
- Pit and Fissure Sealant — all drugs for Pit and Fissure Sealant →
- Permanent Molars — all drugs for Permanent Molars →
Sponsor
Tanta University
Who can join
Adults 6 to 8, any sex, with Resin Infiltration or Pit and Fissure Sealant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate and compare the clinical effectiveness of ICON resin Infiltration versus conventional sealant and the microleakage and penetration depth of the two sealant materials.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06729788
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06729788 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 11 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06729788.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing